Blood Reagents Antitrust Litigation

Welcome to the Blood Reagents Antitrust Litigation Website

UNITED STATES DISTRICT COURT FOR THE
EASTERN DISTRICT OF PENNSYLVANIA

A class has been certified in a class action lawsuit alleging claims against certain manufacturers of Traditional Blood Reagents: Ortho-Clinical Diagnostics, Inc. (“Ortho”) and Immucor, Inc. (“Immucor”) (collectively, the “Defendants”). The Court has scheduled a Trial Date for the litigation against Ortho for June 4, 2018.

If you purchased Traditional Blood Reagents directly from one or both of the Defendants between November 4, 2000 and October 19, 2015, you may be a member of the class described below and this class action lawsuit may affect you.

A class action lawsuit is pending in the United States District Court for the Eastern District of Pennsylvania, in which the Plaintiffs allege that certain blood reagents manufacturers conspired to fix prices in violation of federal antitrust law. The lawsuit claims that, as a result of Defendants’ alleged conduct, the prices paid by individuals and entities for Traditional Blood Reagents were higher than they otherwise would have been. The lawsuit seeks treble damages (triple the amount of actual damages), attorneys’ fees and costs from Defendants. The Defendants deny that any of their conduct was unlawful. The Court has not yet heard or resolved the merits of Plaintiffs’ claims, or determined whether Plaintiffs’ or Defendants’ contentions are true. A trial of this case has been scheduled for June 4, 2018.

In 2012, Immucor settled the lawsuit and paid $22,000,000 for the benefit of a class of purchasers of Traditional Blood Reagents. The Court entered final approval of the Immucor settlement and dismissed Immucor as Defendant. For more information regarding the Immucor settlement, please click here.

The lawsuit continues against the non-settling Defendant, Ortho, on behalf of a class, or group of people, that might include you. The continuing lawsuit affects persons and entities in the United States who purchased Traditional Blood Reagents directly from either Defendant between November 4, 2000 and October 19, 2015 (the “Litigation Class”).

TO DETERMINE WHETHER YOU ARE AFFECTED BY THE PENDING
CLASS ACTION LAWSUIT, PLEASE SEE THE NOTICE FOUND ON THE ‘CLASS NOTICE’ PAGE.

Your rights and options – and the deadlines to exercise them – are explained in the Notice and on this website in the ‘Frequently Asked Questions’ page.

IF YOU HAVE ANY QUESTIONS REGARDING THIS SETTLEMENT, PLEASE DRIECT THEM ONLY TO THE BLOOD REAGENTS ANTITRUST LITIGATION ADMINISTRATOR. DO NOT CONTACT THE COURT OR DEFENDANTS IF YOU HAVE QUESTIONS REGARDING THIS SETTLEMENT